Website under construction

Contact - mehis.pilv@gmail.com

White papers

NEW ANTIVIRALS AGAINST HEPATITIS C BASED ON NOVEL GENE SILECING PLATFORM

GeneCode Ltd. has introduced a new direction in the use of gene silencing agents in therapeutics. The new technology platform is based on oligonucleotide analogs that contain specifically modified DNA bases and that are bound to organic complexes of lanthanides with highly selective artificial nuclease activity.

GeneCode Ltd
Ahtri 8
Tallinn 10151
Estonia